Schedule 13G ownership disclosure
Cascadian Therapeutics Inc
Security class unavailable · CUSIP: 14740B606
Event date: 2017-02-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 3.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-17-000139
- Form type
- SC 13G
- Filer
- BIOTECHNOLOGY VALUE FUND L P
- CIK
- CIK 918923
- Filed
- Feb 02, 2017
- Reporting period
- Feb 02, 2017
- Description
- Schedule 13G beneficial ownership